Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement

Rheumatology (Oxford). 2008 Nov;47(11):1600-2. doi: 10.1093/rheumatology/ken353. Epub 2008 Sep 10.
No abstract available

Publication types

  • Comparative Study
  • Editorial
  • Comment

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • France
  • Guideline Adherence
  • Healthcare Disparities*
  • Humans
  • Patient Selection*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • United Kingdom

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha